October 31, 2024 Endocrinologic and Metabolic Drugs Advisory Committee

Author Avatar

athompson

Joined: Mar 2024
Spread the love


October 31, 2024 Endocrinologic and Metabolic Drugs Advisory Committee


The Committee will discuss new drug application 210934, for sotagliflozin oral tablet, submitted by Lexicon Pharmaceuticals, Inc., for the proposed indication, as an adjunct to insulin therapy, to improve glycemic control in adults with type 1 diabetes mellitus and chronic kidney disease.

source

Reviews

0 %

User Score

0 ratings
Rate This

Sharing

0 0 votes
Article Rating
simple-ad

This is a demo advert, you can use simple text, HTML image or any Ad Service JavaScript code. If you're inserting HTML or JS code make sure editor is switched to 'Text' mode.

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments